Research programme: gene-silencing therapeutics - ReNeuron/Unknown
Latest Information Update: 28 Jul 2024
At a glance
- Originator ReNeuron; Unknown
- Class Exosome therapies
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain disorders
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for research development in Brain-disorders in United Kingdom (Parenteral)
- 28 Jul 2024 No recent reports of development identified for research development in Brain-disorders in USA (Parenteral)
- 25 Jun 2020 Early research in Brain disorders in USA (Parenteral)